Announcements Trials
Browse Landscape

Phase

Phase 3 43Phase 2 23Phase 4 6Phase 1/2 4Phase NA 3Phase 2/3 3Phase 1 3

Status

Completed 2Withdrawn 1Terminated 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 3Other hematologic neoplasm 2Tumor-Agnostic 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Recurrence 1Neoplasms 1Neoplasm Metastasis 1Lymphoma, Non-Hodgkin 1

Interventions

pembrolizumab 410Cyclophosphamide 394Carboplatin 306Gemcitabine 286Nivolumab 276Paclitaxel 274Cisplatin 252Radiotherapy 225Dexamethasone 210Bevacizumab 209fludarabine 192Docetaxel 187Rituximab 183Capecitabine 171Oxaliplatin 158Lenalidomide 157Fluorouracil 152Temozolomide 138Cytarabine 135Etoposide 128Irinotecan 124Cetuximab 123fludarabine phosphate 120Injections 118venetoclax 116Ipilimumab 115Doxorubicin 114Azacitidine 108130-nm albumin-bound paclitaxel 108Pemetrexed 107

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1/2 × Thioguanine × Clear all
NCT05276284 2026-01-14

TEMPLE

Rigshospitalet, Denmark

Phase 1/2 Completed
18 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT00439296 2021-03-17

ABT-751 With Chemotherapy for Relapsed Pediatric ALL

Therapeutic Advances in Childhood Leukemia Consortium

Phase 1/2 Terminated
9 enrolled 12 charts
LymphoidOther hematologic neoplasm

Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02912676 2020-04-15

TEAM

Rigshospitalet, Denmark

Phase 1/2 Completed
30 enrolled
LymphoidOther hematologic neoplasm

Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02141100 2016-10-07

Study of 6-Thioguanine in Combination With 6-Mercaptopurine During Maintenance Therapy of Childhood Lymphoma

Rigshospitalet, Denmark

Phase 1/2 Withdrawn
Lymphoid

Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon âš¡